iBio (IBIO) Retained Earnings (2011 - 2026)
iBio's (IBIO) quarterly Retained Earnings came in at -$354.7 million in Q1 2026, down 8.44% year-on-year from -$387.4 million in Q1 2025, and down 2.23% on a QoQ basis from -$346.9 million in Q4 2025.
iBio (IBIO) Retained Earnings (2011 - 2026) Analysis & Trends
iBio (IBIO) has 16 years of Retained Earnings data on file, last reported at -$354.7 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 8.44% year-over-year to -$354.7 million in Q1 2026; TTM through Mar 2026 was -$354.7 million, a 8.44% decrease from a year earlier, with the FY2025 full-year figure at -$332.2 million, down 5.86% from the prior year.
- Retained Earnings for Q1 2026 stood at -$354.7 million, down from -$346.9 million in the prior quarter.
- Over the last five years, Retained Earnings for IBIO reached as high as -$213000.0 in Q2 2022 and fell as low as -$354.7 million in Q1 2026.
- Historically, Retained Earnings has averaged -$271.2 million across 5 years, with a median of -$306.1 million in 2024.
- Across the five-year window, Retained Earnings jumped 99.88% in 2022 and slumped 135552.58% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$275.6 million in 2022, then decreased by 9.9% to -$302.9 million in 2023, then decreased by 6.37% to -$322.2 million in 2024, then fell by 7.68% to -$346.9 million in 2025, then declined by 2.23% to -$354.7 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$354.7 million in Q1 2026, -$346.9 million in Q4 2025, and -$337.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | -354.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.67 Mn |
| Dec 31, 2025 | -346.94 Mn |
| Sep 30, 2025 | -337.94 Mn |
| Jun 30, 2025 | -332.22 Mn |
| Mar 31, 2025 | -327.06 Mn |
| Dec 31, 2024 | -322.20 Mn |
| Sep 30, 2024 | -317.84 Mn |
| Jun 30, 2024 | -313.85 Mn |
| Mar 31, 2024 | -306.07 Mn |
| Dec 31, 2023 | -302.90 Mn |
| Sep 30, 2023 | -294.69 Mn |
| Jun 30, 2023 | -288.94 Mn |
| Mar 31, 2023 | -282.91 Mn |
| Dec 31, 2022 | -275.61 Mn |
| Sep 30, 2022 | -223,000.00 |
| Jun 30, 2022 | -213,000.00 |
| Mar 31, 2022 | -206.88 Mn |
| Dec 31, 2021 | -194.49 Mn |
| Sep 30, 2021 | -182.57 Mn |
| Jun 30, 2021 | -63,000.00 |